We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

SD BIOSENSOR

SD BIOSENSOR develops immunological and molecular diagnostics and blood glucose self-monitoring systems, glycated hem... read more Featured Products: More products

Download Mobile App




Point-of-Care MDx System Enables Simple, Fast and Accurate Diagnosis in Near Patient Setting

By LabMedica International staff writers
Posted on 22 Mar 2023
Print article
Image: The STANDARD M10 Point-of-Care MDx system (Photo courtesy of SD Biosensor)
Image: The STANDARD M10 Point-of-Care MDx system (Photo courtesy of SD Biosensor)

In the healthcare industry, time is critical. Patients and their loved ones depend on physicians to make rapid and accurate diagnoses, and decisions that can save lives. There's no margin for error and no time to waste. That's where Molecular Diagnostic (MDx) solutions come in. These cutting-edge solutions facilitate the quick and accurate detection of microbial pathogens and provide insights into a patient's genes by combining lab testing with the precision of molecular biology. MDx technologies can effectively perform DNA-level detective work, utilizing millions – or even billions – of replicated copies to gain a more detailed understanding of DNA strands. The resulting insights offer physicians the crucial information they need to make informed diagnostic and therapeutic decisions. Now, an automated point of care MDx system enables rapid, effortless and accurate molecular diagnostic testing of infectious diseases, drug resistance, and genetic testing from human specimens.

The STANDARD M10 from SD Biosensor (Gyeonggi-do, Korea) is a random access and scalable solution that can be utilized for both qualitative as well as quantitative measurement of biomarkers from human samples, like blood, urine, and nasal mucus in a laboratory or POCT environment. The system automatically extracts and amplifies nucleic acids (DNA and RNA) for molecular diagnostics and analyzes the data from amplification in real time. STANDARD M10 is a modular and scalable system, with customized throughput that consists of the STANDARD M10 console (user interface), STANDARD M10 module (cartridge analysis function), and ready-to-use kits. One console can be connected to 1-8 modules, and each module can be used individually, enabling random access testing of patient samples.

The STANDARD M10 combines RT-PCR and isothermal amplification (LAMP) technology in one system, making it a versatile and flexible solution that is suitable for any healthcare settings. It offers multiplex capability, with up to 11 targets + internal control, while providing automated result interpretation and amplification curves. Featuring an intuitive and simple touch screen user interface, the system delivers fast and reliable results in 20-60 minutes with minimal hands-on time of less than three minutes.

Related Links:
SD Biosensor

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Researchers have found the first evidence of testing for the alpha-synuclein protein in blood samples via seed amplification assay (Photo courtesy of Shutterstock)

Blood Test to Detect Alpha-Synuclein Protein Could Revolutionize Parkinson's Disease Diagnostics

Currently, Parkinson's disease (PD) is identified through clinical diagnosis, typically at a later stage in the disease's progression. There is a pressing need for an objective and quantifiable biomarker... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: Ultra-Rapid Antimicrobial Susceptibility Testing (uRAST) revolutionizing traditional antibiotic susceptibility testing (Photo courtesy of Seoul National University)

Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours

Sepsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death.... Read more

Pathology

view channel
Image: The AI model can distinguish different stages of DCIS from inexpensive and readily available breast tissue images (Photo courtesy of David A. Litman/Shutterstock)

AI Model Identifies Breast Tumor Stages Likely To Progress to Invasive Cancer

Ductal carcinoma in situ (DCIS) is a non-invasive type of tumor that can sometimes progress to a more lethal form of breast cancer and represents about 25% of all breast cancer cases. Between 30% and 50%... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.